NON-SMALL CELL LUNG CANCER STAGE IV side effect
What is NON-SMALL CELL LUNG CANCER STAGE IV ?NON-SMALL CELL LUNG CANCER STAGE IV : Remicade Side Effects Report #5632851-X
Health Professional from UNITED KINGDOM reported REMICADE problem on Feb 12, 2008. Female patient, weighting 121.3 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: non-small cell lung cancer stage iv, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, DICLOFENAC, FOLIC ACID, FOSAMAX, ACETAMINOPHEN, RANITIDINE. Patient died on 08/12/2007.
NON-SMALL CELL LUNG CANCER STAGE IV : Remicade Side Effects Report #5499457-7
REMICADE problem was reported by a Physician from UNITED STATES on Oct 17, 2007. Female patient, weighting 120.0 lb, was diagnosed with rheumatoid arthritis, hyperlipidaemia and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: non-small cell lung cancer stage iv, . REMICADE dosage: unknown. During the same period patient was treated with LIPITOR, TYLENOL W, ALLEGRA. Patient was hospitalized. Patient died on 06/01/2007.
NON-SMALL CELL LUNG CANCER STAGE IV : Remicade Side Effects Report #5399185-2
Health Professional from UNITED KINGDOM reported REMICADE problem on July 17, 2007. Female patient, weighting 121.3 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: non-small cell lung cancer stage iv, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, DICLOFENAC, FOLIC ACID, FOSAMAX, ACETAMINOPHEN, RANITIDINE. Patient recovered.
NON-SMALL CELL LUNG CANCER STAGE IV : Remicade Side Effects Report #5399185-2
REMICADE problem was reported by a Health Professional from UNITED KINGDOM on July 17, 2007. Female patient, weighting 121.3 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: non-small cell lung cancer stage iv, . REMICADE dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, DICLOFENAC, FOLIC ACID, FOSAMAX, ACETAMINOPHEN, RANITIDINE. Patient recovered.
NON-SMALL CELL LUNG CANCER STAGE IV : Humira Side Effects Report #5394869-4
Physician from UNITED STATES reported HUMIRA problem on July 13, 2007. Male patient, weighting 180.2 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: metastases to bone, non-small cell lung cancer stage iv, prostatic specific antigen increased, . HUMIRA dosage: unknown. During the same period patient was treated with PHENYTOIN, LOTREL, ASPIRIN, FOLIC ACID, CLOPIDOGREL, SIMVASTATIN, PREDNISONE, METHOTREXATE. Patient recovered.
NON-SMALL CELL LUNG CANCER STAGE IV : Humira Side Effects Report #5394869-4
HUMIRA problem was reported by a Physician from UNITED STATES on July 13, 2007. Male patient, weighting 180.2 lb, was diagnosed with rheumatoid arthritis and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: metastases to bone, non-small cell lung cancer stage iv, prostatic specific antigen increased, . HUMIRA dosage: unknown. During the same period patient was treated with PHENYTOIN, LOTREL, ASPIRIN, FOLIC ACID, CLOPIDOGREL, SIMVASTATIN, PREDNISONE, METHOTREXATE. Patient recovered.
NON-SMALL CELL LUNG CANCER STAGE IV : Docetaxel Side Effects Report #5676088-7
Health Professional from UNITED STATES reported DOCETAXEL problem on Mar 13, 2008. Male patient, 80 years of age, weighting 158.0 lb, was diagnosed with non-small cell lung cancer stage iv, coronary artery disease, cough, fatigue, hyperlipidaemia, hypertension and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, neutropenia, non-small cell lung cancer stage iv, pancytopenia, pneumonia aspiration, pneumothorax, sepsis, . DOCETAXEL dosage: unknown. During the same period patient was treated with SORAFENIB, CARBOPLATIN, ASPIRIN, ROBITUSSIN AC, DEXAMETHASONE, CRESTOR, LISINOPRIL, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 02/20/2008.
NON-SMALL CELL LUNG CANCER STAGE IV : Erlotinib Side Effects Report #5413053-9
ERLOTINIB problem was reported by a Physician from SWITZERLAND on July 25, 2007. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, neoplasm progression, non-small cell lung cancer stage iv, pericardial effusion malignant, pulmonary congestion, syncope, tachycardia, . ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.